Back to Malaria Risk Page INTRODUCTION DISTRIBUTION  OF MALARIA    GLOBAL DISTRIBUTION    DISTRIBUTION IN SOUTH AFRICA PARASITES PROPHYLAXIS AGAINST MALARIA    PRECAUTIONARY MEASURES AGAINST MOSQUITO BITES          Residents of malaria areas     TAKING  OF ANTIMALARIAL DRUGS          Chloroquine resistant areas RECOMMENDATIONS FOR SOUTH AFRICA    RESIDENTS OF MALARIA AREAS RECOMMENDATIONS FOR  OTHER COUNTRIES IN THE WORLD FACTORS INFLUENCING THE SELECTION OF  ANIMALARIAL DRUGS:    PATIENT FACTORS          Infants and young children              Breast-feeding  infants          Pregnancy and lactation          Porphyria          Epilepsy          Chronic illness          Sensitivity to suplha drugs          Exposure to sunlight    ENVIRONMENTAL FACTORS          Duration of stay          Type of accommodation          Time of year COMMENTS ON DRUGS USED FOR CHEMOPROPHYLAXIS    CHLOROQUINE    PROGUANIL    MEFLOQUINE    DOXYCYCLINE STANDBY EMERGENCY TREATMENT OF MALARIA  DRUGS  FOR STANDBY TREATMENT          Sulfadoxine-pyrimethamine          Quinine          Halofantrine DIAGNOSIS AND TREATMENT OF MALARIA REFERENCES TABLE 1 : Antimalarial drugs  used for prophylaxis TABLE 2 : Countries affected by malaria TABLE 3 :Choice of drug(s) according to  patient factors FIGURE  1: Malaria  risk areas in the world 1996/7 FIGURE  2:Malaria  risk areas in South Africa 1996/7 Compiled by the Department of Health in  collaboration with the Subcommittee for Chemoprophylaxis and Therapy of the National  Malaria Advisory Group. October 1996